ClinVar Miner

Submissions for variant NM_003742.4(ABCB11):c.2086C>T (p.Arg696Trp)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV002283409 SCV002571995 uncertain significance not specified 2023-07-28 criteria provided, single submitter clinical testing Variant summary: ABCB11 c.2086C>T (p.Arg696Trp) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4.5e-05 in 177220 control chromosomes (gnomAD). c.2086C>T has been reported in the literature in compound heterozygous state in 2 children, affected with transient neonatal cholestasis and progressive familial intrahepatic cholestasis type 2 (PFIC2) (Liu_2020, Li_2020) and was also reported in heterozygous state in a child with diagnosis for PFIC2 (Hu_2014) and in cohort of patients affected with intrahepatic cholestasis of pregnancy (ICP), however without specifying the genotype of the affected individual(s) (Liu_2020). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 32808743, 24969679, 32309332, 32942997). No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic.
Baylor Genetics RCV003464432 SCV004214990 likely pathogenic Benign recurrent intrahepatic cholestasis type 2 2023-09-08 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV003971229 SCV004784786 likely pathogenic ABCB11-related disorder 2023-12-12 criteria provided, single submitter clinical testing The ABCB11 c.2086C>T variant is predicted to result in the amino acid substitution p.Arg696Trp. This variant was reported in a child with intrahepatic cholestasis (Table 3, Hu et al. 2014. PubMed ID: 24969679). In addition, it was reported with a second ABCB11 variant in patients with neonatal cholestasis (Table 1, Li et al. 2020. PubMed ID: 32808743) or progressive familial intrahepatic cholestasis type 2 (Table S1, Liu et al. 2020. PubMed ID: 32309332). It was also reported in unknown zygosity in intrahepatic cholestasis of pregnancy (Table 2, Liu et al. 2020. PubMed ID: 32942997). This variant is reported in 0.017% of alleles in individuals of South Asian descent in gnomAD. This variant is interpreted as likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.